Biofrontera Inc.
BFRI
$0.7874
-$0.0136-1.70%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 39.36% | 14.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 39.36% | 14.96% | |||
| Cost of Revenue | 8.10% | 12.32% | |||
| Gross Profit | 76.23% | 18.24% | |||
| SG&A Expenses | -2.49% | 6.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.14% | 8.23% | |||
| Operating Income | 65.48% | 2.19% | |||
| Income Before Tax | 75.31% | -2,290.72% | |||
| Income Tax Expenses | -200.00% | -85.00% | |||
| Earnings from Continuing Operations | 75.37% | -2,105.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 75.37% | -2,105.84% | |||
| EBIT | 65.48% | 2.19% | |||
| EBITDA | 65.27% | 2.23% | |||
| EPS Basic | 81.21% | -1,844.16% | |||
| Normalized Basic EPS | 60.09% | -2,137.59% | |||
| EPS Diluted | 62.37% | -1,844.16% | |||
| Normalized Diluted EPS | 60.09% | -2,137.59% | |||
| Average Basic Shares Outstanding | 31.04% | 13.41% | |||
| Average Diluted Shares Outstanding | 31.04% | 13.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
